Plasma GAS6 in the acute phase in AHF patients, is closely associated with several risk factors of adverse prognosis in AHF patients, including NYHA functional class, hypertension and renal dysfunction (evaluated by eGFR). This evidence concerns the gene GAS6 and Hypertension.